SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Beaty O III, Hudson MM, Greenwald C, et al. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol. 1995; 13: 603609.
  • 2
    Bhatia S, Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease [see comments]. N Engl J Med. 1996; 334: 745751.
  • 3
    Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001; 93: 618629.
  • 4
    Abramson DH, Ellsworth RM, Kitchin FD. Second non-ocular tumors in retinoblastoma. Ophthalmology. 1984; 91: 13521355.
  • 5
    Draper GJ, Sanders BM, Kingston JE. Second primary neoplasms in patients with retinoblastoma. Br J Cancer. 1986; 53: 661671.
  • 6
    Wong FL, Boice JD Jr., Abramson DH, et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk [see comments]. JAMA. 1997; 278: 12621267.
  • 7
    Neglia JP, Meadows AT, Robinson LL, et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med. 1991; 325: 13001336.
  • 8
    Nicholson HS, Mulvihill JJ, Byrne J. Late effects of therapy in adult survivors of osteosarcoma and Ewing's sarcoma. Med Pediatr Oncol. 1992; 20: 612.
  • 9
    Pratt CB, Meyer WH, Luo X, et al. Second malignant neoplasms occurring in survivors of osteosarcoma. Cancer. 1997; 80: 960965.
  • 10
    Ferrari C, Bohling T, Benassi MS, et al. Secondary tumors in bone sarcomas after treatment with chemotherapy. Cancer DetectPrev. 1999; 23: 368374.
  • 11
    Moppett J, Oakhill A, Duncan AW. Second malignancies in children: the usual suspects? Eur J Radiol. 2001; 37: 95108.
  • 12
    Rosen G, Murphy ML, Huvos AG, Gutierrez M, Marcove RC. Chemotherapy, en bloc resection and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer. 1976; 37: 111.
  • 13
    Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C, Huvos AG. Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery. Cancer. 1979; 43: 21632177.
  • 14
    Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer. 1982; 49: 12211230.
  • 15
    Rosen G. Pre-operative (neo-adjuvant) chemotherapy for osteogenic sarcoma: a ten year experience. Orthopedics. 1985; 8: 659664.
  • 16
    Kalbfleisch JD, Prentice RL. Introduction, multivariate failure time data and competing risk. In: KalbfleischJD, PrenticeRL. The statistical analysis of failure time data. New York: John Wiley & Sons, 1980: 168171.
  • 17
    Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Am Stat. 1988; 16: 11411154.
  • 18
    Rothman KJ, Boice JD. Epidemiologic analysis with a programmable calculator. NIH publication No. 79-1649. Washington DC: U.S. Government Printing Office, 1979.
  • 19
    RiesLAG, EisnerMP, KosaryCL, et al., editors. SEER cancer statistics review, 1973–1999. Bethesda: National Cancer Institute, 2002. [http://seer.cancer.gov/csr/1973_1999/].
  • 20
    Spurney C, Gorlick R, Meyers PA, Healey JH, Huvos AG. Multicentric osteosarcoma, Rothmund-Thomson syndrome, and secondary nasopharyngeal non-Hodgkin's lymphoma: a case report and review of literature. J Pediatr Hematol Oncol. 1998; 20: 494497.
  • 21
    Ozaki T, Sugihara S, Inoue H. Second malignant neoplasm after treatment of osteosarcoma: a report of three cases. Acta Med Okayama. 1993; 47: 129133.
  • 22
    Jacobs AD, Gale RP. Acute myelogenous leukemia following radiation therapy and chemotherapy for osteogenic sarcoma. Cancer Treat Rep. 1984; 68: 909911.
  • 23
    Fenaux P, Jouet SP, Bauters F. Translocation t(9;11) (p21:q23) with acute myelomonocytic leukemia after chemotherapy for osteosarcoma: good response to antileukemic drugs. J Clin Oncol. 1987; 5: 13041305.
  • 24
    Davies SV, Murray JA, Browser-Riley SM. Secondary leukemia with a transformation (8:21)? Cancer Genet Cytogenet. 1988; 31: 271274.
  • 25
    Orazi A, Sozzi G, Morandi F, Rottoli L, Cattoretti G. Acute monoblastic leukemia as a second malignancy following chemotherapy for osteosarcoma: a case report. Pediatr Hematol Oncol. 1988; 5: 3946.
  • 26
    Whang-Peng J, Young RC, Lee EC, Longo DL, Schechter GP, DeVita VT Jr. Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. Blood. 1988; 71: 403414.
  • 27
    Sozzi G, Miozzo M, Orazi A, et al. Cytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphoblastic leukemia (t-ANLL). Br J Cancer. 1990; 61: 425428.
  • 28
    Kapelushnik J, Dube I, Wilson P, Greenberg M. Acute lymphoblastic leukemia with t(4;11) translocation after osteogenic sarcoma. Cancer. 1991; 67: 28872889.
  • 29
    Pappo A, Schneider NR, Sanders JM, Buchanan GR. Secondary myelodysplastic syndrome complicating therapy for osteogenic sarcoma. Cancer. 1991; 68: 13731375.
  • 30
    Pui CH, Ribeiro RC, Hancock ML, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med. 1991; 325: 16821687.
  • 31
    Kushner BH, Cheung NK, Kramer K, Heller G, Jhanwar SC. Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering Cancer experience and a literature review. J Clin Oncol. 1998; 16: 38803889.
  • 32
    LeBeau MM, Albain KS, Larson RA, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphoblastic leukemia: further evidence for characteristic abnormalities of chromosomes. J Clin Oncol. 1986; 4: 325345.
  • 33
    Kantarjian HM, Keating MJ, Walters RS, et al. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. J Clin Oncol. 1986; 4: 17481757.
  • 34
    Levine EG, Bloomfield C. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin Oncol. 1992; 19: 4784.
  • 35
    Felix CA, Hosler MR, Winick NJ, Masterson M, Wilson AE, Lange BJ. ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemias in children. Blood. 1995; 85: 32503256.
  • 36
    Pedersen-Bjergaard J, Pedersen M, Roulston D, Philip P. Different genetic pathways in leukemogenesis for patients presenting with therapy-related acute myeloid leukemia. Blood. 1995; 86: 35423552.
  • 37
    Cimino G, Rapanotti MC, Biondi A, et al. Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias. Cancer Res. 1997; 57: 28792883.
  • 38
    Rubin CM, Arthur DC, Woods WG, et al. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy. Blood. 1991; 78: 29822988.
  • 39
    Sandoval C, Pui CH, Bowman LC, et al. Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation. J Clin Oncol. 1993; 11: 10391045.
  • 40
    Bhatia S, Krailo M, Schwartz C, Robison LL, Meyers PA. Therapy-related myelodysplasia (t-MDS/t-AML) following treatment of children with osteosarcoma[abstract 1473]. Am Soc Clin Oncol. 2001; 20: 369a.
  • 41
    Jeha S, Jaffe N, Robertson R. Secondary acute non-lymphoblastic leukemia in two children following treatment with a cis-diaminedichloroplatinum-II-based regimen for osteosarcoma. Med Pediatr Oncol. 1992; 20: 7174.
  • 42
    Hutchison GB. Late neoplastic changes following medical irradiation. Cancer. 1976; 37: 11021107.
  • 43
    Li FP. Second malignant tumors after cancer of childhood. Cancer. 1977; 40: 18991902.
  • 44
    Hawkins MM, Wilson LM, Burton HS, et al. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst. 1996; 88: 270278.
  • 45
    Tucker MA, D'Angio GJ, Boice JD, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med. 1978; 317: 588593.
  • 46
    McIntyre JF, Smith-Sorensen B, Friend SH, et al. Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol. 1994; 12: 925230.
  • 47
    Strong LC, Stine M, Norsted TL. Cancer in survivors of childhood soft tissue sarcoma and their relatives. J Natl Cancer Inst. 1987; 79: 12131220.